EPISODE · Jul 19, 2018 · 30 MIN
MaxCyte (MXCT) presentation at ShareSoc July 2018
from PIWORLD Investor Podcasts · host piworld
Driving the next generation of cell-based medicines By Doug Doerfler – Founder, President & CEO Introduction – 00:23 Background and what MaxCyte does - 02:41 Business model – 04:11 CARMA platform, CAR therapy in oncology - 09:07 Cell therapy programmes – business model – 16:12 Revenue potential across multiple applications – 19:15 Expected news flow - 21:36 Summary & outlook – 22:18 2017 financial highlights - 22:50 Q&A - 23:45
What this episode covers
Driving the next generation of cell-based medicinesBy Doug Doerfler – Founder, President & CEO Introduction – 00:23Background and what MaxCyte does - 02:41Business model – 04:11CARMA platform, CAR therapy in oncology - 09:07Cell therapy programmes – business model – 16:12Revenue potential across multiple applications – 19:15Expected news flow - 21:36Summary & outlook – 22:182017 financial highlights - 22:50Q&A - 23:45
NOW PLAYING
MaxCyte (MXCT) presentation at ShareSoc July 2018
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m